Pharmacyclics, Inc.
(408) 774-0330
995 East Arques Avenue
Sunnyvale, California,
USA
94085
Pharmacyclics, Inc. is a biopharmaceutical company that designs, develops and commercializes novel therapies intended to improve quality of life, increase duration of life and resolve serious medical healthcare needs.
Products & Services
-
- Pcyc
- Pharmacyclics
- Inc.
- Biopharmaceutical Company
- Silicon Valley Biotech
-
- Motexafin Gadolinium - Mgd
- Hdac Inhibitors
- Btk Inhibitors
- Factor Viia Inhibitor
Web Result
- RTOG 0513 MGdGlioblastoma
- About Us Executive Management Board of Directors Corporate Governance Contact Us Pipeline BTK Inhibitor PCI-32765 and Inhibitor Series for Autoimmune Diseases Histone Deacetylase Inhibitor Program Factor VIIa InhibitorPCI-27483 Motexafin Gadolinium Glossary of Terms Clinical Trials BTK Inhibitors - ReferencesB-cell Lymphoma PCYC 1102 CA BTK InhibitorCLL/SLL PCYC 1103 CA BTK InhibitorB-cell Lymphom...
- Request for Information
- About Us Executive Management Board of Directors Corporate Governance Contact Us Clinical Trials BTK Inhibitors - ReferencesB-cell Lymphoma PCYC 1102 CA BTK InhibitorCLL/SLL PCYC 1103 CA BTK InhibitorB-cell Lymphoma and CLL PCYC 1104 CA BTK InhibitorRelapsed or Refractory Mantle cell Lymphoma PCYC 1106 CA BTK InhibitorRelapsed or Refractory Non-Hodgkin s DLBCL Lymphoma PCYC 1108 CA BTK InhibitorCh...
- Chronic Lymphocytic Leukemia...
- About Us Executive Management Board of Directors Corporate Governance Contact Us Clinical Trials Clinical Trials Overview Ibrutinib (PCI-32765),BTK-inhibitor PCI-27483,Factor VIIa-inhibitor Abexinostat HCl (PCI-24781),PanHDAC-inhibitor Glossary of Terms Pipeline Bruton's Tyrosine Kinase (BTK) Inhibitor Program Histone Deacetylase Inhibitor Program Factor VIIa Inhibitor Motexafin Gadolinium Glossar...
- Mantle Cell Lymphoma
- Multiple Myeloma
Website Links:
None | Abexinostat HCI (PCI-27483)... | Bruton's Tyrosine Kinase... | Btk Inhibitor for Autoimmune... | BTK Inhibitors - Animation | BTK Inhibitors - References | BTK Inhibitors - ReferencesB-cell... | Chronic Lymphocytic Leukemia... | Clinical Trials | Diffuse Large B-cell Lymphoma | Executive Management | Factor VIIa Inhibitor | Factor VIIa Inhibitor... | Glossary of Terms | HDAC Inhibitor for Oncology... | HDAC Inhibitors - Animation | HDAC Inhibitors - References | Histone Deacetylase Inhibitor... | Ibrutinib (PCI-32765)... | Mantle Cell Lymphoma
Own this business?
Request to update the information